Achieving end-to-end continuous bioprocessing without introducing surges and pooling remains a goal for biomanufacturers. As they transition from vat to hybrid or continuous processing, ...

New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.

Running a thousand virtual scale-up simulations before touching a single real-world valve is no longer a theoretical ambition. Digital twins in biomanufacturing have matured from concept to ...

Single-use biomanufacturing has shifted the default expectation for process monitoring: instead of pulling manual samples and waiting for offline analysis, modern disposable bioreactors arrive with ...

New, more flexible and affordable benchtop system is designed for the flexibility and customizability demanded by preclinical research, process development, and translational applicationsRIO RANCHO, N ...

Brevel, Ltd. enters fully into the plant cell-culture market to help companies scale-up production and enhance nutrients yield, utilizing its proprietary illuminated fermentation platform. Brevel is ...

Pow.Bio’s technology advantage includes the first ever AI-controlled, automated fermentation platform The raise is helping Pow.Bio to expand operations with a state of the art demonstration plant in ...

Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity ...

Introducing sustainability goals to long standing, established industries can be difficult. However, global environmental awareness and ramped up regulations are proving to help make changes across ...

Sartorius and LFB Biomanufacturing expand their CDMO partnership, integrating engineered CHO cell lines with GMP manufacturing capabilities.

With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...

Acquisition strengthens Biosphere’s advanced bioreactor platform and accelerates development of bioproducts across ...